Nuveen’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.48M Sell
199,003
-11,372
-5% -$366K ﹤0.01% 1777
2025
Q4
$7.4M Buy
210,375
+15,217
+8% +$539K ﹤0.01% 1730
2025
Q3
$5.13M Buy
195,158
+3,268
+2% +$97.5K ﹤0.01% 1891
2025
Q2
$5.09M Sell
191,890
-192,489
-50% -$5.07M ﹤0.01% 1872
2025
Q1
$9.28M Buy
384,379
+64,511
+20% +$2.04M ﹤0.01% 1597
2024
Q4
$12.9M Buy
319,868
+1,868
+0.6% +$107K ﹤0.01% 1461
2024
Q3
$20.1M Buy
318,000
+115,307
+57% +$6.76M 0.01% 1193
2024
Q2
$10.7M Sell
202,693
-258,389
-56% -$16.9M ﹤0.01% 1534
2024
Q1
$37.8M Buy
461,082
+193,462
+72% +$8.61M 0.01% 772
2023
Q4
$4.98M Buy
267,620
+3,336
+1% +$43.6K ﹤0.01% 1980
2023
Q3
$2.93M Sell
264,284
-311
-0.1% -$4.45K ﹤0.01% 2134
2023
Q2
$4.29M Buy
264,595
+251,647
+1,944% +$5.27M ﹤0.01% 1999
2023
Q1
$216K Buy
+12,948
New +$134K ﹤0.01% 2979
2022
Q2
Sell
-263,132
Closed -$855K 3491
2022
Q1
$855K Sell
263,132
-522,881
-67% -$1.88M ﹤0.01% 2866
2021
Q4
$3.57M Sell
786,013
-327,359
-29% -$1.83M ﹤0.01% 2289
2021
Q3
$7.45M Buy
1,113,372
+829,824
+293% +$5.13M ﹤0.01% 1987
2021
Q2
$1.7M Sell
283,548
-13,210
-4% -$78.4K ﹤0.01% 2786
2021
Q1
$1.88M Sell
296,758
-13,262
-4% -$93.3K ﹤0.01% 2652
2020
Q4
$1.75M Sell
310,020
-191,168
-38% -$1.16M ﹤0.01% 2576
2020
Q3
$2.92M Buy
501,188
+252,718
+102% +$1.74M ﹤0.01% 2199
2020
Q2
$1.79M Sell
248,470
-5,956
-2% -$39.5K ﹤0.01% 2387
2020
Q1
$1.19M Sell
254,426
-533
-0.2% -$3.28K ﹤0.01% 2429
2019
Q4
$2.04M Sell
254,959
-167,442
-40% -$1.22M ﹤0.01% 2412
2019
Q3
$2.91M Buy
422,401
+143,876
+52% +$1.07M ﹤0.01% 2236
2019
Q2
$2.31M Buy
+278,525
New +$2.38M ﹤0.01% 2368
2019
Q1
Sell
-82,960
Closed -$635K 1083
2018
Q4
$635K Buy
82,960
+54,731
+194% +$654K ﹤0.01% 782
2018
Q3
$492K Buy
+28,229
New +$336K ﹤0.01% 865

Other funds holding VKTX